DK0701815T3 - Fremgangsmåde til fremstilling af aktivstofholdige pulvere, granulater eller pellets med en grundstruktur af hydrofile makr - Google Patents

Fremgangsmåde til fremstilling af aktivstofholdige pulvere, granulater eller pellets med en grundstruktur af hydrofile makr

Info

Publication number: DK0701815T3
Authority: DK; Denmark
Prior art keywords: hydrophilic; macar; pellets; granules; preparation
Prior art date: 1992-01-17

Application number

DK95113398T

Other languages

English (en)

Inventor

Ursula Schick

Juergen Werry

Juergen Freidenreich

Jens-Christian Wunderlich

Original Assignee

Alfatec Pharma Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-01-17

Filing date

1993-01-18

Publication date

2000-02-07

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27435369&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0701815(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1992-01-17 Priority claimed from DE4201179A external-priority patent/DE4201179A1/de

1992-01-17 Priority claimed from DE4201173A external-priority patent/DE4201173C2/de

1993-01-18 Application filed by Alfatec Pharma Gmbh filed Critical Alfatec Pharma Gmbh

2000-02-07 Application granted granted Critical

2000-02-07 Publication of DK0701815T3 publication Critical patent/DK0701815T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0216—Solid or semisolid forms
- A61K8/022—Powders; Compacted Powders
- A61K8/0225—Granulated powders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1658—Proteins, e.g. albumin, gelatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Birds (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Molecular Biology (AREA)
Mycology (AREA)
Microbiology (AREA)
Botany (AREA)
Biotechnology (AREA)
Biophysics (AREA)
Dermatology (AREA)
Medicinal Preparation (AREA)
Cosmetics (AREA)
Compositions Of Macromolecular Compounds (AREA)
Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Processes Of Treating Macromolecular Substances (AREA)
Fire-Extinguishing Compositions (AREA)
Treatments Of Macromolecular Shaped Articles (AREA)
Absorbent Articles And Supports Therefor (AREA)
Glanulating (AREA)

DK95113398T 1992-01-17 1993-01-18 Fremgangsmåde til fremstilling af aktivstofholdige pulvere, granulater eller pellets med en grundstruktur af hydrofile makr DK0701815T3 (da)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
DE4201179A DE4201179A1 (de)	1992-01-17	1992-01-17	Wirkstoff(e) enthaltendes granulat oder pellet mit einem geruest aus hydrophilen makromolekuelen und verfahren zu seiner herstellung
DE4201173A DE4201173C2 (de)	1992-01-17	1992-01-17	Akutarzneimittel in Form von Dihydropyridinderivaten enthaltenden Pellets und ihre Herstellung
US07/876,864 US5405616A (en)	1992-01-17	1992-04-30	Means for containing active substances, having a shell of hydrophilic macromolecules, active substances and process for preparation thereof
US07/876,877 US5384129A (en)	1992-01-17	1992-04-30	Pellets containing dihydropyridine derivatives process for the production thereof and use as rapid action dosage in heart and circulatory diseases

Publications (1)

Publication Number	Publication Date
DK0701815T3 true DK0701815T3 (da)	2000-02-07

Family

ID=27435369

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK93902034.3T DK0621777T3 (da)	1992-01-17	1993-01-18	Pellets indeholdende aktivt stof og med en matrix af hydrofile makromolekyler, og fremgangsmåde til deres fremstilling
DK95113398T DK0701815T3 (da)	1992-01-17	1993-01-18	Fremgangsmåde til fremstilling af aktivstofholdige pulvere, granulater eller pellets med en grundstruktur af hydrofile makr

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK93902034.3T DK0621777T3 (da)	1992-01-17	1993-01-18	Pellets indeholdende aktivt stof og med en matrix af hydrofile makromolekyler, og fremgangsmåde til deres fremstilling

Country Status (10)

Country	Link
EP (2)	EP0701815B1 (da)
JP (1)	JPH07502736A (da)
AT (2)	ATE181666T1 (da)
AU (1)	AU679906B2 (da)
CA (1)	CA2128244C (da)
DE (2)	DE59303759C5 (da)
DK (2)	DK0621777T3 (da)
ES (2)	ES2092808T3 (da)
GR (2)	GR3021223T3 (da)
WO (1)	WO1993013757A1 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2714575B1 (fr) *	1994-01-03	1996-02-02	Rhone Poulenc Nutrition Animal	Nouveaux granulés contenant des organismes vivant pour l'alimentation animale.
SE9704401D0 (sv) *	1997-11-28	1997-11-28	Astra Ab	Matrix pellets for greasy, oily or sticky drug substances
DE50105469D1 (de) *	2001-03-22	2005-04-07	Cognis Iberia Sl	Mikrokapseln (VII)
US6835802B2 (en)	2001-06-04	2004-12-28	Nobex Corporation	Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
US6713452B2 (en)	2001-06-04	2004-03-30	Nobex Corporation	Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6828297B2 (en)	2001-06-04	2004-12-07	Nobex Corporation	Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6828305B2 (en)	2001-06-04	2004-12-07	Nobex Corporation	Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US7713932B2 (en)	2001-06-04	2010-05-11	Biocon Limited	Calcitonin drug-oligomer conjugates, and uses thereof
FR2843302B1 (fr)	2002-08-09	2004-10-22	Centre Nat Rech Scient	Forme galenique pour la delivrance colique de principes actifs
FR2843301B1 (fr) *	2002-08-09	2004-10-22	Centre Nat Rech Scient	Forme galenique pour la delivrance colique de principes actifs
EP1551373B1 (de) *	2002-10-16	2014-11-12	MedSkin Solutions Dr. Suwelack AG	Verwendung von formkörpern zur äusseren anwendung
US9107804B2 (en)	2002-12-10	2015-08-18	Nortec Development Associates, Inc.	Method of preparing biologically active formulations
UA91512C2 (ru)	2004-07-19	2010-08-10	Биокон Лимитед	Коньюгати олигомеров инсулина, их композиция (варианты) и применение
FR2887455B1 (fr) *	2005-06-28	2007-08-10	Sanofi Aventis Sa	Formulation a liberation prolongee de principes actifs de medicaments
AU2007295178B2 (en) *	2006-09-15	2013-04-18	Echo Pharmaceuticals B.V.	Granulate containing a pharmaceutically active substance and anemulsifier and method for its manufacture
CN101541299B (zh)	2006-09-15	2013-04-17	艾可制药有限公司	供舌下、口含或口服施用的不溶于水的药物活性物质的剂量单位
US8273376B2 (en)	2006-11-17	2012-09-25	Da Volterra	Colonic delivery of metallo-dependent enzymes
BRPI1001091A2 (pt)	2009-04-22	2011-03-22	Dr Suwelack Skin & Health Care Ag	artigo moldado revestido secado por congelamento
WO2014022195A1 (en) *	2012-08-01	2014-02-06	Tavakoli Zahra	Free flowing, frozen compositions comprising a therapeutic agent
ITMI20122145A1 (it) *	2012-12-14	2014-06-15	Velleja Res Srl	Composizioni per uso orale contenenti idrolizzati di collagene, di elastina e vitamina c favorenti la deposizione di matrice extra-cellulare
LU102656B1 (de)	2021-03-11	2022-09-12	Prosecur Gmbh	Flüssiges Nahrungsergänzungsmittel zur Immunstimulation, Verfahren zu dessen Herstellung sowie Verwendung

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1248863B (da) *	1959-01-30
GB887901A (da) *	1960-04-13	1900-01-01
IE53696B1 (en) *	1981-12-02	1989-01-18	Wyeth John & Brother Ltd	Solid shaped articles
EP0138216B1 (en) *	1983-10-14	1993-01-07	Sumitomo Pharmaceuticals Company, Limited	Sustained-release ifn preparation for parenteral administration
US4837285A (en) *	1984-03-27	1989-06-06	Medimatrix	Collagen matrix beads for soft tissue repair
US4642903A (en) *	1985-03-26	1987-02-17	R. P. Scherer Corporation	Freeze-dried foam dosage form
FR2634121B1 (fr) *	1988-07-13	1992-05-07	Imedex	Procede de preparation de microparticules de collagene et produits obtenus
JPH02135052A (ja) *	1988-11-17	1990-05-23	Taiyo Kagaku Co Ltd	粒状食品の製造方法
US5007790A (en) *	1989-04-11	1991-04-16	Depomed Systems, Inc.	Sustained-release oral drug dosage form
FR2650502B1 (fr) *	1989-08-07	1994-05-27	Delagrange Laboratoires	Nouvelle forme galenique orale ameliorant la biodisponibilite
US5079018A (en) *	1989-08-14	1992-01-07	Neophore Technologies, Inc.	Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
US5215756A (en) *	1989-12-22	1993-06-01	Gole Dilip J	Preparation of pharmaceutical and other matrix systems by solid-state dissolution
ATE156350T1 (de)	1992-01-17	1997-08-15	Alfatec Pharma Gmbh	Peptidarzneistoffe enthaltende pellets und ihre herstellung sowie deren verwendung
ES2102637T3 (es)	1992-01-17	1997-08-01	Alfatec Pharma Gmbh	Cuerpos moldeados criogranulados que contienen un extracto de sustancias vegetales activas y su utilizacion farmaceutica o cosmetica.
ATE132036T1 (de)	1992-01-17	1996-01-15	Alfatec Pharma Gmbh	Verfahren zur herstellung von weichgelatinekapseln nach einem tropfverfahren
DE4221880A1 (de) *	1992-07-03	1994-01-05	Alfatec Pharma Gmbh	Feste und flüssige Lösungen von schwer wasserlöslichen Arzneistoffen

1993
- 1993-01-18 CA CA002128244A patent/CA2128244C/en not_active Expired - Fee Related
- 1993-01-18 AT AT95113398T patent/ATE181666T1/de not_active IP Right Cessation
- 1993-01-18 DE DE59303759T patent/DE59303759C5/de not_active Expired - Lifetime
- 1993-01-18 EP EP95113398A patent/EP0701815B1/de not_active Expired - Lifetime
- 1993-01-18 DK DK93902034.3T patent/DK0621777T3/da active
- 1993-01-18 ES ES93902034T patent/ES2092808T3/es not_active Expired - Lifetime
- 1993-01-18 ES ES95113398T patent/ES2133633T3/es not_active Expired - Lifetime
- 1993-01-18 DK DK95113398T patent/DK0701815T3/da active
- 1993-01-18 WO PCT/DE1993/000038 patent/WO1993013757A1/de active IP Right Grant
- 1993-01-18 AT AT93902034T patent/ATE142484T1/de not_active IP Right Cessation
- 1993-01-18 DE DE59309678T patent/DE59309678D1/de not_active Expired - Fee Related
- 1993-01-18 JP JP5512079A patent/JPH07502736A/ja active Pending
- 1993-01-18 EP EP93902034A patent/EP0621777B1/de not_active Expired - Lifetime
- 1993-01-18 AU AU33432/93A patent/AU679906B2/en not_active Ceased
1996
- 1996-10-02 GR GR960402577T patent/GR3021223T3/el unknown
1999
- 1999-07-01 GR GR990401751T patent/GR3030675T3/el unknown

Also Published As

Publication number	Publication date
DE59303759D1 (de)	1996-10-17
ES2092808T3 (es)	1996-12-01
AU3343293A (en)	1993-08-03
EP0701815A1 (de)	1996-03-20
JPH07502736A (ja)	1995-03-23
CA2128244C (en)	1998-09-22
EP0701815B1 (de)	1999-06-30
WO1993013757A1 (de)	1993-07-22
ES2133633T3 (es)	1999-09-16
GR3021223T3 (en)	1997-01-31
EP0621777A1 (de)	1994-11-02
EP0621777B1 (de)	1996-09-11
DK0621777T3 (da)	1996-10-21
AU679906B2 (en)	1997-07-17
ATE142484T1 (de)	1996-09-15
DE59309678D1 (de)	1999-08-05
GR3030675T3 (en)	1999-11-30
CA2128244A1 (en)	1993-07-22
DE59303759C5 (de)	2009-04-09
ATE181666T1 (de)	1999-07-15

Publication	Publication Date	Title
DK0701815T3 (da)	2000-02-07	Fremgangsmåde til fremstilling af aktivstofholdige pulvere, granulater eller pellets med en grundstruktur af hydrofile makr
ATE248922T1 (de)	2003-09-15	Hormonanaloge mit mehreren ctp-erweiterungen
NO954188D0 (no)	1995-10-19	Modifisert-protein- og -peptid - farmasöytika
DE69034091D1 (de)	2003-09-04	Herstellung von Hämoglobin und Analogen davon in Nicht-Erythrozytzellen
DE3875108D1 (de)	1992-11-05	Physiologisch aktives polypeptid und pharmazeutische komposition.
ATE194917T1 (de)	2000-08-15	Flüssige beta-interferon formulierungen
ATE109206T1 (de)	1994-08-15	O-glycosylierter igf-1.
NO903844D0 (no)	1990-09-04	Medikamentavgivelsesblandinger basert paa biologiske celler eller komponenter derav og fremgangsmaater.
ES2052513T3 (es)	1994-07-16	Nuevos polipeptidos, su fabricacion y empleo.
ATE123056T1 (de)	1995-06-15	Ancrod-proteine, ihre herstellung und verwendung.
RU92004553A (ru)	1995-05-20	Стабилизированная фармацевтическая композиция на основе рекомбинантного, негликозилированного 1l-2 человека в восстановленном виде и способ ее получения
DE59106997D1 (de)	1996-01-11	Ancrod ähnliche proteine, ihre herstellung und verwendung.
Jarrett	1988	Personality and artistic creativity
DE3873115D1 (de)	1992-09-03	Polypeptid mit antiviraler wirkung, und seine anwendung.
DE58904296D1 (de)	1993-06-17	N-benzoyl-n'-trifluorphenylharnstoffe, ihre herstellung und verwendung bei der kontrolle von schaedlingen.
IT208506Z2 (it)	1988-05-28	Struttura di castone perfezionato, realizzabile su anelli ed altri gioielli, atta a facilitare l'operazione di incastonatura di brillanti e simili ed a garantirne una perfetta stabilita', nella relativa sede.